<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.9.1" -->
<rss version="0.92">
<channel>
	<title>Intravenous Therapy News and Updates with IVTEAM</title>
	<link>http://www.ivteam.com</link>
	<description>IV news and views with Andrew Jackson</description>
	<lastBuildDate>Sat, 13 Mar 2010 22:24:47 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Durospan vascular catheter</title>
		<description><![CDATA[
Intravenous products: r4 Vascular announces the commercial availability of the new Duraspan Biomimetic Coated long-term hemodialysis catheter. A novel coating on the catheter surface mimics the glycocalyx layer found on natural endothelial tissue surfaces in vessel walls. Laboratory tests of the DuraspanTM catheter have demonstrated an 87% reduction in platelet adhesion and thrombus accumulation compared [...]]]></description>
		<link>http://www.ivteam.com/durospan-vascular-catheter/</link>
			</item>
	<item>
		<title>Safer IV medication development</title>
		<description><![CDATA[
Intravenous products: MarketWatch.com report &#8220;MedPro Safety Products, a leading developer of transformational technologies that enable safer medication delivery and blood collection, has entered into a Joint Development Agreement (JDA) with Belgium-based Helvoet Pharma for the technical development and commercialization of MedPro&#8217;s pre-filled safety syringe (PFSS).
MedPro&#8217;s PFSS passive safety device is a proprietary pre-filled medicament delivery [...]]]></description>
		<link>http://www.ivteam.com/safer-iv-medication-development/</link>
			</item>
	<item>
		<title>IV administration recall</title>
		<description><![CDATA[
Intravenous products: MarketWatch.com report &#8220;Teleflex Incorporated provided an update today on the previously announced Arrow International, Inc. voluntary recall of ALL lots of its Arrow custom intravenous administration products (IV tubing sets and accessories) and certain Arrow arterial embolectomy catheters distributed prior to February 19, 2010 .
Testing revealed pin holes in some of the pouches [...]]]></description>
		<link>http://www.ivteam.com/iv-administration-recall/</link>
			</item>
	<item>
		<title>Vascular access device choice</title>
		<description><![CDATA[
Intravenous literature: Roszell, S. (2010) Intravenous Administration Issues: A Comparison of Intravenous Insertions and Complications in Vancomycin Versus Other Antibiotics. Journal of Infusion Therapy. 33(2), p.112-118.
Abstract:
Nurses on a surgical unit compared 2 groups of patients, vancomycin versus other antibiotics, to determine whether vancomycin intravenous therapy is associated with more peripheral intravenous (PIV) complications. Data were [...]]]></description>
		<link>http://www.ivteam.com/vascular-access-device-choice/</link>
			</item>
	<item>
		<title>Infusion reaction management</title>
		<description><![CDATA[
Intravenous literature: Namey, M., Halper, J., O&#8217;Leary, S., Beavin, J. and Bishop, C. (2010) Best Practices in Multiple Sclerosis: Infusion Reactions Versus Hypersensitivity Associated With Biologic Therapies. Journal of Infusion Therapy. 33(2), p.98-111.
Abstract:
Infusion nurses are uniquely positioned to play a vital role in the early identification and management of infusion and hypersensitivity reactions during the [...]]]></description>
		<link>http://www.ivteam.com/infusion-reaction-management/</link>
			</item>
	<item>
		<title>Platelet refractory response</title>
		<description><![CDATA[
Intravenous literature: Eisenberg, S. (2010) Refractory Response to Platelet Transfusion Therapy. Journal of Infusion Therapy. 33(2), p.89-97.
Abstract:
Platelet transfusions are commonly used for prophylaxis and treatment of bleeding. After a transfusion, an increment or “boost” is expected to occur. While a number of factors can contribute to a poor posttransfusion increment, refractoriness is typically defined as [...]]]></description>
		<link>http://www.ivteam.com/platelet-refractory-response/</link>
			</item>
	<item>
		<title>Therapeutic phlebotomy</title>
		<description><![CDATA[
Intravenous literature: Cook, L. (2010) Therapeutic Phlebotomy: A Review of Diagnoses and Treatment Considerations. Journal of Infusion Therapy. 33(2), p.81-88.
Abstract:
In the United States, phlebotomies are most often performed for reinfusion of blood to a designated or nondesignated recipient at a later time. These are known, respectively, as autologous or allogenic donations. For a few rare [...]]]></description>
		<link>http://www.ivteam.com/therapeutic-phlebotomy/</link>
			</item>
	<item>
		<title>Nine rights of medication administration</title>
		<description><![CDATA[
Intravenous literature: Elliott, M. and Liu, Y. (2010) The nine rights of medication administration: an overview. British Journal of Nursing. 19(5), p.300-305.
Abstract:
Nurses are responsible for ensuring safety and quality of patient care at all times. Many nursing tasks involve a degree of risk, and medication administration arguably carries the greatest risk. Unfortunately, patients are frequently [...]]]></description>
		<link>http://www.ivteam.com/nine-rights-of-medication-administration/</link>
			</item>
	<item>
		<title>AVA 2010 abstract submission</title>
		<description><![CDATA[
Intravenous conference: The Association for Vascular Access has made a call for abstract of submissions. Abstracts are being accepted for podium and poster presentations for the 24th Annual Scientific Meeting of the Association of Vascular Access, September 24-26, 2010 in National Harbor, MD (Washington DC area).
Presentations MUST fit one of the following categories; the category [...]]]></description>
		<link>http://www.ivteam.com/ava-2010-abstract-submission/</link>
			</item>
	<item>
		<title>Neonatal device-associated BSI</title>
		<description><![CDATA[
Intravenous literature: Balkhy, H.H. et al (2010) Neonatal rates and risk factors of device-associated bloodstream infection in a tertiary care center in Saudi ArabiaAmerican Journal of Infection Control. 38(2), p.159-161.
Abstract:
In a prospective surveillance study, we examine the risk of device-associated bloodstream infection (BSI) in a neonatal intensive care unit at Riyadh, Saudi Arabia, during 2006 and [...]]]></description>
		<link>http://www.ivteam.com/neonatal-device-associated-bsi/</link>
			</item>
</channel>
</rss>
